Dermapharm - Pharmaceutical Excellence “Made in Germany”:
Dermapharm is a leading manufacturer of patent-free branded pharmaceuticals for selected markets in Germany. Founded in 1991,
the company is based in Grünwald near Munich and has its main manufacturing facility in Brehna near Leipzig. The company’s
integrated business model comprises in-house development, in-house production and distribution of pharmaceuticals and other
healthcare products for specifically targeted markets by a medical and pharmaceutical sales force. Dermapharm holds approximately
900 marketing authorizations (Arzneimittelzulassungen) for more than 250 active pharmaceutical ingredients, which are marketed as
pharmaceuticals, dietary supplements or supplemental balanced diets. This assortment makes the company unique. In addition to
Germany, the company’s core markets also include Austria and Switzerland. The company plans to further expand its international
presence. Dermapharm’s business model also includes a parallel import business, which operates under the “axicorp” brand. Based on
revenues, Dermapharm was among the top five parallel import companies in Germany in 2018. In the "Herbal Extracts" segment,
Dermapharm has access to the growth market for plant pharmaceuticals through the Spanish company Euromed S.A., one of the
leading manufacturers of plant extracts and plant-based active ingredients.
With a consistent development strategy and numerous successful product and company acquisitions over the past 25 years,
Dermapharm has continuously optimized its business and provided external growth impulses in addition to organic growth.
Dermapharm intends to continue this profitable growth course in the future. The company is focusing on a three-pillar
strategy: in-house development of new products, increase of its international footprint and further acquisitions.